Real-World Study Confirms Benefits of Guselkumab in Active Longstanding PsAMarch 14, 2024Psoriatic Arthritis
Guselkumab Superior to Ustekinumab for Joint and Skin Outcomes in PsAMarch 14, 2024Psoriatic Arthritis
Certain Gut Microbiota and Serum Metabolites May Protect Against PsAMarch 14, 2024Psoriatic Arthritis
Bimekizumab Shows Long-term Benefits in PsA with Inadequate Response or Intolerance to TNFiMarch 14, 2024Psoriatic Arthritis
Ixekizumab Improves Distal Interphalangeal Joint Involvement and Adjacent Nail Psoriasis in PsAMarch 14, 2024Psoriatic Arthritis
Rheumatology NewsAI’s Future and Current Role in RheumatologyMarch 14, 2024Business of MedicineRheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathies
Rheumatology NewsRA Outcomes Worsened by Depression and Anxiety, Signaling Need for Multidisciplinary ActionMarch 13, 2024Rheumatoid Arthritis
Rheumatology NewsSafe Steroid Tapering in Lupus: Reducing Flares, DamageMarch 13, 2024Lupus & Connective Tissue Diseases
Rheumatology NewsNew Cancer Surgical Tech Gets Positive Vote, But Some Cite Safety ConcernsMarch 8, 2024
